Human‐engineered Treg‐like cells suppress FOXP3‐deficient T cells but preserve adaptive immune responses <i>in vivo</i>
Yohei Sato(Jikei University School of Medicine), Rosa Bacchetta(Lucile Packard Children's Hospital), Silvia Gregori(The San Raffaele Telethon Institute for Gene Therapy), Molly Javier Uyeda(California Institute for Regenerative Medicine), Alice Bertaina(Stanford University), Brian Piening(Stanford University), Laura Passerini(The San Raffaele Telethon Institute for Gene Therapy), M Snyder(Stanford University), Maria‐Grazia Roncarolo(Vita-Salute San Raffaele University), Marianne Goodwin(Stanford University)
Cited by 54
Related Papers
Global Analysis of Protein Activities Using Proteome Chips
|Science|2001|1.9k
The NASA Twins Study: A multidimensional analysis of a year-long human spaceflight
|Science|2019|1.1k
Gene Therapy for Immunodeficiency Due to Adenosine Deaminase Deficiency
|New England Journal of Medicine|2009|1k
How many human proteoforms are there?
|Nature Chemical Biology|2018|945